Table 1.
Tissue | Cell Type | Biomaterial | Printed Model | Outcome | Reference |
---|---|---|---|---|---|
Skin | |||||
2016–2018 | |||||
Human dermal endothelial cells | Sodium alginate, chitosan, gelatin, gellan gum, collagen I (core materials), pure alginate (shell material) | Core/shell construct |
|
Akkineni et al. 2016 | |
Human fibroblasts (hFB) and keratinocytes (hKC) obtained from skin biopsies of healthy donors | Plasma-derived fibrin scaffold | Skin: dermis + epidermis |
|
Cubo et al. 2016 | |
Human primary dermal fibroblasts, human primary epidermal keratinocytes | Newly-developed ECM-like bioInk | Skin model |
|
Rimann et al. 2016 | |
Amniotic fluid-derived stem (AFS) cells | Photo-cross-linkable heparin-conjugated hyaluronic acid (HA-HP) hydrogel | In situ skin graft |
|
Skardal et al. 2016 | |
Fibroblasts | Collagen hydrogel | Dermal construct |
|
Hou et al. 2017 | |
Human fibroblasts and human keratinocytes | Unique bioink of alginate, gelatin, fibrinogen | Skin: dermis + epidermis |
|
Pourchet et al. 2017 | |
Human primary skin cells (fibroblasts and keratinocytes) | Collagen, gelatin. PCL (prevents collagen shrinkage) | Skin: dermis + epidermis |
|
Kim et al. 2017 | |
Keratinocytes (KCs), melanocytes (MCs) and fibroblasts (FBs) (from three different Caucasian skin donors) | Collagen, PVP (Polyvinylpyrrolidone) polymer | Pigmented skin: bioprinting vs. manual-cast approach |
|
Ng et al. 2018 | |
Endothelial progenitor cells (EPCs) and adipose-derived stem cells (ASCs) added to HDF (human dermal fibroblast) and HEK (human epidermal keratinocyte) | Skin-derived extracellular matrix (S-dECM) bioink, collagen I matrix (as a control) | Skin patch |
|
Kim et al. 2018 | |
Fibroblasts, melanocytes and keratinocytes | Collagen hydrogel | Pigmented skin model (dermal + epidermal layer) |
|
Min et al. 2018 | |
Human melanocytes (HEM), human keratinocytes (HaCat) and human dermal fibroblasts (HDF) | Gelatin methacrylamide (GelMA) and collagen (Col)+ tyrosinase (Ty) | Living skin model |
|
Shi et al. 2018 | |
2019–2020 | |||||
Fibroblasts and keratinocytes | Hydrogel (fibrinogen, collagen I, trombin) | In situ skin bioprinting |
|
Albanna et al. 2019 | |
Neonatal human dermal fibroblasts and neonatal normal human epithelial keratinocytes | Gelatin, fibrinogen, collagen, elastin (dermal hydrogel) | Skin equivalent |
|
Derr et al. 2019 | |
Human fibroblasts, keratinocytes, human umbilical vein endothelial cells (HUVECs), preadipocytes | dECM-based bioinks, gelatin hydrogel. PCL transwell system (supportive mesh) | A vascularized tri-layered skin model (epidermis, dermis, and hypodermis) |
|
Kim et al. 2019 | |
Human amniotic epithelial cells (AECs), Wharton’s jelly-derived mesenchymal stem cells (WJMSCs) | Alginate/gelatin composite hydrogels | Skin bilayered construct |
|
Liu et al. 2019 | |
No cells | PCL and silk sericin for epidermis + CS_SA hydrogel for dermis (CS, chitosan; SA, sodium alginate) | Composite skin construct: three-dimensional skin asymmetric construct (3D_SAC) |
|
Miguel et al. 2019 | |
Human dermal fibroblasts (HDFs) | Skin decellularized extracellular matrix (dECM) | Bioprinted 3D construct |
|
Won et al. 2019 | |
Neonatal human dermal fibroblasts (NHDFs), immortalized human keratinocyte cell line (HaCaT) and human umbilical vein endothelial cells (HUVECs) | Methacrylated gelatin (GelMA) and succinylated chitosan/dextran aldehyde | Prevascularized core/shell construct for wound healing |
|
Turner et al. 2020 | |
Human-derived skin fibroblasts (hSF) | Bioink made of nanofibrillated cellulose (NFC), alginate (ALG) and carboxymethyl cellulose (CMC) | Dermal construct |
|
Zidaric et al. 2020 |